BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infect Dis 2019;6:ofy353. [PMID: 30931346 DOI: 10.1093/ofid/ofy353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Brunner P, Brunner K, Kübler D. The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review. AIDS Behav 2022;26:2279-98. [PMID: 35034238 DOI: 10.1007/s10461-022-03583-y] [Reference Citation Analysis]
2 Tu F, Yang R, Wang W, Li R, Du G, Liu Y, Li W, Wei P. Analysis of Knowledge, Attitude and Practice of Hepatitis B Among Freshmen in Jiangsu Based on Lasso-Logistic Regression and Structural Equation Model. Infect Drug Resist 2022;15:3063-73. [PMID: 35734538 DOI: 10.2147/IDR.S365728] [Reference Citation Analysis]
3 Prabhu M, Susich MK, Packer CH, Hersh AR, Riley LE, Caughey AB. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis. Obstet Gynecol 2022;139:357-67. [PMID: 35115449 DOI: 10.1097/AOG.0000000000004652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Li R, Lin X, Wang JY, Wang X, Lu J, Liu Y, Cao Z, Ren S, Ma L, Jin Y, Zheng S, Hu Z, Wang L, Chen X. Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China. Ann Transl Med 2021;9:1365. [PMID: 34733917 DOI: 10.21037/atm-21-1666] [Reference Citation Analysis]
5 Abbas Z, Abbas M. Challenges in Formulation and Implementation of Hepatitis B Elimination Programs. Cureus 2021;13:e14657. [PMID: 33907651 DOI: 10.7759/cureus.14657] [Reference Citation Analysis]
6 Leech MM, Briggs A, Loehrer AP. Surgical Diseases are Common and Complicated for Criminal Justice Involved Populations. J Surg Res 2021;265:27-32. [PMID: 33872846 DOI: 10.1016/j.jss.2021.02.050] [Reference Citation Analysis]
7 Rosenthal EM, Hall EW, Rosenberg ES, Harris A, Nelson NP, Schillie S. Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations. Vaccine 2020;38:8206-15. [PMID: 33160756 DOI: 10.1016/j.vaccine.2020.10.067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Prabhu M, Riley LE. Universal Screening and Vaccination for Hepatitis B in Pregnancy: The Time Is Now. Obstet Gynecol 2020;135:808-11. [PMID: 32168212 DOI: 10.1097/AOG.0000000000003706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Alpern JD, Leventhal TM, Bahr NC. Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program. J Health Care Poor Underserved 2020;31:1037-43. [PMID: 33416677 DOI: 10.1353/hpu.2020.0077] [Reference Citation Analysis]
10 Toy M, Hutton DW, So S. Economic Analyses to Inform and Support Health Policy for Chronic Hepatitis B Treatment. Curr Hepatology Rep 2019;18:357-62. [DOI: 10.1007/s11901-019-00482-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]